Clinical trials
Breast Cancer Lymphedema trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
123 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2015 | 2 |
| 2016 | 8 |
| 2017 | 4 |
| 2018 | 7 |
| 2019 | 11 |
| 2020 | 10 |
| 2021 | 15 |
| 2022 | 11 |
| 2023 | 10 |
| 2024 | 13 |
| 2025 | 15 |
| 2026 | 11 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 57 |
| Unknown status | 22 |
| Recruiting | 17 |
| Not yet recruiting | 12 |
| Active, not recruiting | 9 |
| Terminated | 2 |
| Withdrawn | 2 |
| Suspended | 1 |
| Enrolling by invitation | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Marmara University | 6 |
| Cairo University | 4 |
| Massachusetts General Hospital | 4 |
| Assiut University | 3 |
| Dokuz Eylul University | 3 |
| Ege University | 3 |
| Koya Medical, Inc. | 3 |
| Odense University Hospital | 3 |
| Samsung Medical Center | 3 |
| Violeta Pajero Otero | 3 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Breast Cancer Lymphedema | 123 |
| Lymphedema | 49 |
| Breast Neoplasms | 46 |
| Neoplasm Metastasis | 4 |
| Edema | 3 |
| Pain | 3 |
| Postoperative Complications | 3 |
| Breast Carcinoma In Situ | 1 |
| Breast Diseases | 1 |
| COVID-19 | 1 |
Trials
Showing 1 to 25 of 123. Each trial links to its page on Pharma Observatory.
23 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.